Measles vaccine

ApprovedVaccine

GSK

Measles vaccine is one of 109 biologic programs targeting Japanese encephalitis. It is currently in Approved.

Indications

Total Trials

Active Trials

108

Competitors

Pipeline

Status by Indication[3][1]

Indication

Japanese EncephalitisActive, not recruiting

HepatitisActive, not recruiting

MortalityActive, not recruiting

Hepatitis BActive, not recruiting

Japanese EncephalitisPhase 3

Active, not recruiting

HepatitisApproved

Active, not recruiting

MortalityApproved

Active, not recruiting

Hepatitis BPhase 3

Active, not recruiting

Competition

Competitive Landscape

252 competitors in Hepatitis B

#DrugCompanyPhaseTrials

Viread

Gilead

Phase 3

4 2

Virazole

CConrado Roberto Hoffmann Filho

Phase 3

3 3

Measles vaccine

GSK

Approved

1 4

Hydronidone

BBeijing Continent Pharmaceutical Co, Ltd.

Phase 3

2 5

Dtpa-Ipv/hib Vaccine

GSK

Phase 3

1 6

Dtpa-HBV-Ipv/hib

GSK

Phase 3

1 7

Vemlidy

Gilead

Preclinical

8 8

HBVAXPRO Vaccine

HHenogen

Phase 3

2 9

HB-AS02V

HHenogen

Phase 3

2 10

Baraclude

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Post-ApprovalRecruiting

Vaccines

NCT04899765

Clinical

Trials by Indication[1]

Vaccination2 trials

Measles Vaccination at Health System Contacts

Enrolling by invitation·BBandim Health Project·Phase 4·NCT04220671·5,400 enrolled

Early Two-dose Measles Vaccination Trial

Completed·BBandim Health Project·Phase 4·NCT00168558·5,879 enrolled

Measles Vaccine2 trials

Additional Measles Vaccine at 4 Months of Age

Unknown status·BBandim Health Project·Phase 4·NCT01486355

A Second Dose of Measles Vaccine (MV) in the Second Year of Life

Completed·BBandim Health Project·N/A·NCT02943681·3,812 enrolled

Pediatric1 trial

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Completed· Sanofi logo

Sanofi·Phase 3·NCT05794230·1,528 enrolled

Randomized Controlled Trial1 trial

Randomized Controlled Trial of Measles Vaccination Schedule

Unknown status·PPost Graduate Institute of Medical Education and Research, Chandigarh·N/A·NCT03170765·120 enrolled

Children1 trial

Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

Completed·UUniversity of North Carolina, Chapel Hill··NCT02058927·203 enrolled

8 more indications

Hepatitis B1 trial

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

Completed· GSK logo

GSK·Phase 3·NCT01345240·705 enrolled

Immunology1 trial

Immunology of Non-specific Effects of Vaccine

Completed·BBandim Health Project·Phase 4·NCT00168545·400 enrolled

Vaccines1 trial

Measles and BCG Vaccines for Mother and Child

Recruiting·BBandim Health Project·Phase 4·NCT04899765·2,400 enrolled

Hepatitis1 trial

Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine

Unknown status·UUniversity of Witwatersrand, South Africa·Phase 4·NCT03330171·278 enrolled

Japanese encephalitis1 trial

Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

Completed·PPATH·Phase 3·NCT00249769·600 enrolled

Rotavirus Vaccine1 trial

Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali

Completed·PPATH·Phase 4·NCT02286895·600 enrolled

Long-term Follow-up1 trial

Long-term Follow-up of Measles Antibodies

Completed·BBandim Health Project·Phase 4·NCT00168571·1,960 enrolled

Mortality1 trial

Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children

Completed·BBandim Health Project·Phase 4·NCT03460002·28,612 enrolled

Sources

References

[1]
ClinicalTrials.gov — 15 trial records for Measles vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Measles vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Measles vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Approved[1]
Company: GSK

Measles vaccine

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Vaccination2 trials

Measles Vaccine2 trials

Pediatric1 trial

Randomized Controlled Trial1 trial

Children1 trial

Hepatitis B1 trial

Immunology1 trial

Vaccines1 trial

Hepatitis1 trial

Japanese encephalitis1 trial

Rotavirus Vaccine1 trial

Long-term Follow-up1 trial

Mortality1 trial

References

Drug Info

Quick Facts

Related News